Novo Nordisk (NOVOB)

Sector:

Medicine and Biotech Research

Index:

OMX Copenhagen

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Dk 270.00
   
  • 52 Week High: Dk332.00
  • 52 Week Low: Dk234.50
  • Currency: Denmark Kroner
  • Shares Issued: 448.07m
  • Market Cap: Dk120,980m

Novo Nordisk Overview

Novonordisk is a pharmaceutical company focussed on diabetes treatment. It also operates in haemostasis management, growth hormone therapy and hormone replacement therapy. It employs over 26,000 people across 79 countries and markets its products in 180 countries.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 2.2
Op Mrgn 33.7%
ROCE 59.6%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 9.2%
PBT 19.9%
EPS 21.9%
DPS 40.0%

Novo Nordisk Fundamentals

Year Ending Revenue (Dkm) Pre-tax (Dkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 41,831.00 10,971.00 13.49Dk n/a n/a +436% 4.50 0.0%
31-Dec-08 45,553.00 12,695.00 15.66Dk 17.3 1.1 +16% 6.00 2.2%
31-Dec-09 51,078.00 13,988.00 17.97Dk n/a n/a +15% 7.50 0.0%
31-Dec-10 60,776.00 18,286.00 24.81Dk n/a n/a +38% 10.00 0.0%
31-Dec-11 66,346.00 21,925.00 30.24Dk n/a n/a +22% 14.00 0.0%

Novo Nordisk Forecasts

Novo Nordisk Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Novo Nordisk Market Data

Currency Denmark Kroner
% Change -3.74 %
52 Week High Dk332.00
52 Week Low Dk234.50
Shares Issued 448.07m
Market Cap Dk120,980m

What The Brokers Say

Strong Buy 13
Buy 4
Neutral 13
Sell 3
Strong Sell 2
Total 35
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page